378 related articles for article (PubMed ID: 29899003)
21. An evaluation of the performance of the Dynamiker® Fungus (1-3)-β-D-Glucan Assay to assist in the diagnosis of Pneumocystis pneumonia.
White PL; Posso RB; Gorton RL; Price JS; Wey E; Barnes RA
Med Mycol; 2018 Aug; 56(6):778-781. PubMed ID: 29087494
[TBL] [Abstract][Full Text] [Related]
22. Pneumocystis polymerase chain reaction and blood (1→3)-β-D-glucan assays to predict survival with suspected Pneumocystis jirovecii pneumonia.
Matsumura Y; Ito Y; Yamamoto M; Matsushima A; Nagao M; Takakura S; Iinuma Y; Ichiyama S
J Infect Chemother; 2014 Feb; 20(2):109-14. PubMed ID: 24480550
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of a Novel Plasma (1,3)-β-d-Glucan Detection Assay for Diagnosis of Candidemia in Pediatric Patients.
Liu Y; Chen F; Zhu X; Shen L; Zhang SX
J Clin Microbiol; 2015 Sep; 53(9):3017-20. PubMed ID: 26109441
[TBL] [Abstract][Full Text] [Related]
24. Serum (1 → 3) β-D-glucan assay for discrimination between Pneumocystis jirovecii pneumonia and colonization.
Tasaka S; Kobayashi S; Yagi K; Asami T; Namkoong H; Yamasawa W; Ishii M; Hasegawa N; Betsuyaku T
J Infect Chemother; 2014 Nov; 20(11):678-81. PubMed ID: 25066434
[TBL] [Abstract][Full Text] [Related]
25. Serum (1,3)-Beta-d-Glucan has suboptimal performance for the diagnosis of Pneumocystis jirovecii pneumonia in cancer patients and correlates poorly with respiratory burden as measured by quantitative PCR.
Szvalb AD; Malek AE; Jiang Y; Bhatti MM; Wurster S; Kontoyiannis DP
J Infect; 2020 Sep; 81(3):443-451. PubMed ID: 32650108
[TBL] [Abstract][Full Text] [Related]
26. (1,3)-β-D-glucan is able to predict therapeutic failure of patients with candidemia and not only mortality.
Esteves P; Lopes Lima S; Salles de Azevedo Melo A; Maria Beirão E; Nucci M; Colombo AL
Mycoses; 2021 Mar; 64(3):264-271. PubMed ID: 33274533
[TBL] [Abstract][Full Text] [Related]
27. Detailed β-(1→3)-D-glucan and mannan antigen kinetics in patients with candidemia.
Träger J; Dräger S; Mihai S; Cipa F; Busse Grawitz A; Epting T; Meyer R; Rappold E; Held J
J Clin Microbiol; 2023 Nov; 61(11):e0059823. PubMed ID: 37823667
[TBL] [Abstract][Full Text] [Related]
28. Serological biomarkers of candidemia: a retrospective evaluation of three assays.
Dichtl K; Seybold U; Wagener J
Infection; 2019 Apr; 47(2):217-224. PubMed ID: 30264200
[TBL] [Abstract][Full Text] [Related]
29. Serum (1,3)-beta-D-glucan is an inefficient marker of breakthrough candidemia.
Abe M; Kimura M; Araoka H; Taniguchi S; Yoneyama A
Med Mycol; 2014 Nov; 52(8):835-40. PubMed ID: 25349254
[TBL] [Abstract][Full Text] [Related]
30. Serum (1-3)-beta-D-glucan as a tool for diagnosis of Pneumocystis jirovecii pneumonia in patients with human immunodeficiency virus infection or hematological malignancy.
Desmet S; Van Wijngaerden E; Maertens J; Verhaegen J; Verbeken E; De Munter P; Meersseman W; Van Meensel B; Van Eldere J; Lagrou K
J Clin Microbiol; 2009 Dec; 47(12):3871-4. PubMed ID: 19846641
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic accuracy of the 1,3-β-D-glucan test for pneumocystis pneumonia in a tertiary university hospital in Denmark: A retrospective study.
Engsbro AL; Najat S; Jørgensen KM; Kurtzhals JAL; Arendrup MC
Med Mycol; 2019 Aug; 57(6):710-717. PubMed ID: 30535059
[TBL] [Abstract][Full Text] [Related]
32. Blood (1->3)-beta-D-glucan as a diagnostic test for HIV-related Pneumocystis jirovecii pneumonia.
Sax PE; Komarow L; Finkelman MA; Grant PM; Andersen J; Scully E; Powderly WG; Zolopa AR;
Clin Infect Dis; 2011 Jul; 53(2):197-202. PubMed ID: 21690628
[TBL] [Abstract][Full Text] [Related]
33. Post-diagnostic kinetics of the (1 → 3)-β-D-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumonia.
Koo S; Baden LR; Marty FM
Clin Microbiol Infect; 2012 May; 18(5):E122-7. PubMed ID: 22404638
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic accuracy of serum (1-3)-β-D-glucan for Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis.
Del Corpo O; Butler-Laporte G; Sheppard DC; Cheng MP; McDonald EG; Lee TC
Clin Microbiol Infect; 2020 Sep; 26(9):1137-1143. PubMed ID: 32479781
[TBL] [Abstract][Full Text] [Related]
35. Clinical evaluation of a (1,3)-beta-D-glucan assay for presumptive diagnosis of Pneumocystis jiroveci pneumonia in immunocompromised patients.
Del Bono V; Mularoni A; Furfaro E; Delfino E; Rosasco L; Miletich F; Viscoli C
Clin Vaccine Immunol; 2009 Oct; 16(10):1524-6. PubMed ID: 19692624
[TBL] [Abstract][Full Text] [Related]
36. β-D-glucan and S-adenosylmethionine serum levels for the diagnosis of Pneumocystis pneumonia in HIV-negative patients: a prospective study.
de Boer MG; Gelinck LB; van Zelst BD; van de Sande WW; Willems LN; van Dissel JT; de Jonge R; Kroon FP
J Infect; 2011 Jan; 62(1):93-100. PubMed ID: 20970450
[TBL] [Abstract][Full Text] [Related]
37. Levels of beta-D-glucan in Candida auris supernatants, an in vitro and in vivo preliminary study.
Mikulska M; Furfaro E; Magnasco L; Codda G; Giacobbe DR; Dentone C; Vena A; Marchese A; Bassetti M
Clin Microbiol Infect; 2022 Aug; 28(8):1154.e1-1154.e3. PubMed ID: 35283316
[TBL] [Abstract][Full Text] [Related]
38. Clinical utility of serum beta-D-glucan and KL-6 levels in Pneumocystis jirovecii pneumonia.
Nakamura H; Tateyama M; Tasato D; Haranaga S; Yara S; Higa F; Ohtsuki Y; Fujita J
Intern Med; 2009; 48(4):195-202. PubMed ID: 19218768
[TBL] [Abstract][Full Text] [Related]
39. Lower beta-1,3-D-glucan testing cut-offs increase sensitivity for non-albicans Candida species bloodstream infections.
Forster J; Dichtl K; Wagener J
Mycoses; 2022 May; 65(5):500-507. PubMed ID: 35020235
[TBL] [Abstract][Full Text] [Related]
40. Combination of β-(1, 3)-D-glucan testing in serum and qPCR in nasopharyngeal aspirate for facilitated diagnosis of Pneumocystis jirovecii pneumonia.
Desoubeaux G; Chesnay A; Mercier V; Bras-Cachinho J; Moshiri P; Eymieux S; De Kyvon MA; Lemaignen A; Goudeau A; Bailly É
Mycoses; 2019 Nov; 62(11):1015-1022. PubMed ID: 31494981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
